Synthace

On December 14th, 2014 Synthace announced that it raised $3,500,000 in seed funding from Sofinnova Partners, SOSventuresSOSventures, Bioeconomy Capital, and the Rainbow Seed Fund.

Antha is an open source language anda cloud based operating platform made by Synthace. Antha is made to help scientists design, execute, analyze, and replicate aspects of their lab work. The company claims that Antha can produce a 100-fold improvement in lab productivity, a 50% reduction in the time it takes to generate internal vector constructions, a 33% reduction in the cost of running experiments, and increase enzymatic activity by 100X compared to pre-Antha platforms. Below you can find brief descriptions of specific services Antha software offers to users which are: construct assembly, data integration, and liquid handling.

Synthace completed its series A funding round on SeptmberSeptember 19th, 2017. They received $9,600,000 in funding from White Cloud Capital (Luminous Ventures), Sofinnova Partners, SOSventures, Bioeconomy Capital, Amadeus Capital, and 11.2 Capital.

Oxford Biomedica is the lead partner in this partnership between Synthace, CellCell and Gene Therapy Catapult, and Stratophase. The partnerships between these companies was announced in August, 2017 and is focused on developing more efficient cell and gene manufacturing systems and technologies.